| Financial Year |
March 31 2023 |
| Monetary Funds |
9,869,091,597.48 |
| Held-for-trading Financial Assets |
80,726,583.58 |
| Notes Receivable |
73,000,000.00 |
| Accounts Receivable |
6,625,200,535.85 |
| Advances to Suppliers |
339,891,027.62 |
| Other Receivables |
104,847,325.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,843,131,558.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,204,992,328.98 |
| Other Current Assets |
1,040,396,236.31 |
| Total Current Assets |
27,502,389,642.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,150,568,600.72 |
| Investment Properties |
-- |
| Fixed Assetes |
14,576,009,099.57 |
| Under-construction Projects |
7,790,722,052.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
1,018,947,000.00 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,892,782,935.28 |
| R&D expenses |
-- |
| Goodwill |
1,824,895,982.02 |
| Long-Term Deferred and Prepaid Expenses |
1,746,530,457.28 |
| Deferred Income Tax Assets |
425,308,448.28 |
| Other Non-Current Assets |
73,740,368.11 |
| Sub-Total of Non-Current Assets |
40,685,698,982.32 |
| Total Assets |
68,188,088,624.62 |
| Short-Term Loans |
4,186,904,159.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,357,519.03 |
| Accounts Payable |
2,007,584,835.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,354,982,878.24 |
| Taxes Payable |
745,543,466.09 |
| Interest Payable |
3,017,878.44 |
| Dividend Payable |
-- |
| Other payables |
3,484,870,904.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
277,391,187.06 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
15,786,215,710.63 |
| Long-term Loans |
189,849,246.19 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
411,448,132.53 |
| Other Non-Current Liabilities |
59,128.71 |
| Sub-Total of Non-Current Liabilities |
2,570,870,388.83 |
| Total Liabilities |
18,357,086,099.46 |
| Paid-In Capital(Or Share Stock) |
2,967,323,062.00 |
| Capital Surplus |
27,223,109,328.13 |
| Surplus Reserve |
702,680,509.92 |
| LESS:Treasury Stock |
2,728,309,132.99 |
| Undistributed Profits |
21,304,603,428.61 |
| Minority Stockholder's Interest |
356,119,898.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
49,474,882,627.12 |
| Owner's Equity（Stockholder's Equity） |
49,831,002,525.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
68,188,088,624.62 |
